Barely Significant
← all excerpts

A phase II trial of sorafenib in metastatic melanoma with tissue correlates.

PLoS One · 2010 · PMC3012061 · PMID 21206909

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.